{3 (10 ML inebilizumab-cdon 10 MG/ML Injection [Uplizna]) } Pack [Uplizna 3 Vial Kit]
- RxCUI
- 2373967
- RxNorm name
- {3 (10 ML inebilizumab-cdon 10 MG/ML Injection [Uplizna]) } Pack [Uplizna 3 Vial Kit]
- Display name
- {3 (10 ML inebilizumab-cdon 10 MG/ML Injection [Uplizna]) } Pack [Uplizna 3 Vial Kit]
- Full name
- {3 (10 ML inebilizumab-cdon 10 MG/ML Injection [Uplizna]) } Pack [Uplizna 3 Vial Kit]
- Term type
- BPCK
- Status
- DailyMed mapping
- Updated
- 2026-06-04 23:39:06
Purple Book Biologic Products#
| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|---|---|---|---|---|
| 761142 | Uplizna | inebilizumab-cdon | 351(a) | Rx | 2026-08-01 |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| UPLIZNA | INEBILIZUMAB | Horizon Therapeutics USA, Inc. | 834db232-afb0-4dcf-93e0-009ce8245c20 | 2025-12-11 | Warnings, Adverse reactions | 2373967 |
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| 834db232-afb0-4dcf-93e0-009ce8245c20 | {3 (10 ML inebilizumab-cdon 10 MG/ML Injection [Uplizna]) } Pack [Uplizna 3 Vial Kit] [BPCK] · UPLIZNA 3 Vial Kit [PSN] · Uplizna 3 Vial Kit [SY] | 3 | 9 | These highlights do not include all the information needed to use UPLIZNA ® safely and effectively. See full prescribing information for UPLIZNA ® . UPLIZNA ® (inebilizumab-cdon) injection, for intravenous use Initial U.S. Approval: 2020 | 20251211 |